FDA Oncology Division Director Says Goal to Make Review Process “Predictable”
Three Bomb Threats At NIH In One Week result In Evacuations, Investigations
FDA Oncology Division To Develop Papers On Expectations for New Drugs
DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers
With workload Up, Oncology Division To Add More Staff
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?









